Correction (DOI:10.1016/S0735-1097(00)01050-0);Factors affecting long-term survival (>10 years) after cardiac transplantation in the cyclosporine era

Journal of the American College of Cardiology

Volumn 37, Issue 1, 2001, Pages 189-194

  John, Ranjit ^a,b   Rajasinghe, Hiranya A ^a   Itescu, Silviu ^a   Suratwalla, Sanjeev ^a   Lietz, Katherine ^a   Weinberg, Alan D ^a   Kocher, Alfred ^a   Mancini, Donna M ^a   Drusin, Ronald E ^a   Oz, Mehmet C ^a   Smith, Craig R ^a   Rose, Eric A ^a   Edwards, Niloo M ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b Milstein Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ADULT; ANALYTIC METHOD; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HEART DISEASE; HEART EJECTION FRACTION; HEART INDEX; HEART TRANSPLANTATION; HUMAN; IMMUNE STATUS; INTRAOPERATIVE PERIOD; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; ORGAN DONOR; PATIENT INFORMATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION;

EID: 0035173965     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.02.001     Document Type: Erratum

References (30)

1. The registry of the international society for heart and lung transplantation: Sixteenth official report-1999
2. Long-term survival after cardiac retransplantation: A 20 year single center experience
3. Cardiac transplantation: The Stanford experience in the cydosporine era
4. Eight-year results of cyclosporine-treated patients with cardiac transplants
5. Causes of late failure after heart transplantation: A ten-year survey
6. Studies on the orthotopic homotransplantation of the canine heart
7. Nonparametric estimation from incomplete observations
8. Regression models and life tables
9. Early results with partial left ventriculectomy
10. Multicenter clinical evaluation of the Heartmate 1000 IP left ventricular assist device
11. Barriers to xenotransplantation
12. Characteristics of patients surviving more than 10 years after cardiac transplantation
13. Long-term myocardial function after heart transplantation
14. Long-term hemodynamic results after cardiac transplantation
15. Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients
16. Influence of allograft coronary artery disease on survival and cardiac function in the decade following orthotopic cardiac transplantation
17. Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantation
18. Effect of pravastatin on outcomes after cardiac transplantation
19. A preliminary study of diltiazem in prevention of coronary artery disease in heart transplant recipients
20. The role of donor age and ischemic time on survival following orthotopic heart transplantation
21. Anti-endothelial cell antibodies and coronary artery disease after cardiac transplantation
22. The relationship among donor-recipient HLA mismatches, rejection and death from coronary artery disease in cardiac transplant recipients
23. Influence of acute rejection episodes, HLA matching, and donor-recipient phenotype on the development of 'early' transplant-associated coronary artery disease
24. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis
25. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease
26. Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching
27. An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients
28. Influence of HLA mismatch on rejection after heart transplantation, a multi-institutional study: The cardiac transplant research database group
29. HLA-DR mismatching correlated with early cardiac allograft rejection, incidence, and graft survival when high-confidence level serological DR typing is used
30. Impact of current management practices on early and late mortality in over 500 consecutive cardiac transplant recipients